36 completed, 24 recruiting, 19 not yet recruiting, 5 active not recruiting. 24 Phase 4, 20 Phase 3, 17 Phase 2, 8 Not applicable, 8 Phase 1.
Follow finerenone: new trials by email Literature Review of finerenone trials Research Report on finerenone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial Finerenone (BAY94-8862 ) 10 mg, Placebo - Acute Kidney Injury, Renal Insufficiency,Chronic | Not applicable | Not yet recruiting | Jean-Maxime Côté | 72 | 2027-01-01 | 2026-08-20 |
| Precision T1D Platform - New Therapies for Cardio-Renal Complications Finerenone, Sotagliflozin - Type 1 Diabetes, T1D Heart Failure | Phase 2 | Not yet recruiting | Oregon Health and Science University | 57 | 2026-11-01 | 2026-08-10 |
| A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social) Finerenone - Type 2 Diabetes, Chronic Kidney Disease (CKD) Stages G2 to G3b | Not yet recruiting | Bayer | 800 | 2026-10-30 | 2026-10-21 | |
| Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure Finerenone, Placebo - HFpEF - Heart Failure With Preserved Ejection Fraction, TAVI(Transcatheter Aortic Valve Implantation) | Phase 3 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2832 | 2026-10-09 | 2026-10-16 |
| Finerenone's Impact on Cardiac Electrical Stability in HFpEF Finerenone, Placebo - Heart Failure and Preserved Ejection Fraction, Atrial Fibrillation (AF) | Not yet recruiting | Assiut University | 100 | 2026-10-01 | 2026-10-08 | |
| Role of Finerenone in African American Veterans With Diabetic Kidney Disease Finerenone 10 MG, Empagliflozin 10 MG - Diabetic Kidney Disease | Phase 4 | Not yet recruiting | Washington D.C. Veterans Affairs Medical Center | 30 | 2026-10-01 | 2026-08-21 |
| Finerenone and Cardiac Remodeling in HFpEF Finerenone, Standard of care for HFpEF Description: - Heart Failure With Preserved Ejection Fraction | Phase 4 | Not yet recruiting | Assiut University | 194 | 2026-09-20 | 2026-09-22 |
| Finerenone for Premature Ovarian Insufficiency (POI) Finerenone, Placebo - Premature Ovarian Insufficiency | Phase 2 | Not yet recruiting | The University of Hong Kong-Shenzhen Hospital | 46 | 2026-09-15 | 2026-09-11 |
| Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria Finerenone, Finerenone Placebo, Semaglutide - Obesity; Chronic Kidney Disease; Albuminuria | Not applicable | Not yet recruiting | Peking University People's Hospital | 266 | 2026-09-01 | 2026-09-30 |
| QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy empagliflozin, Finerenone, Mazdutide - Type 2 Diabetic Kidney Disease | Phase 4 | Not yet recruiting | Huijie Zhang | 820 | 2026-09-01 | 2026-08-20 |
| Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis Finerenone - Type 2 Diabetes Mellitus, Diabetic Kidney Disease | Not yet recruiting | First Affiliated Hospital of Chongqing Medical University | 425 | 2026-07-30 | 2026-07-21 | |
| Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial Empagliflozin and Finerenone, Placebo for Empagliflozin and Finerenone - Hypertension (HTN) | Not applicable | Not yet recruiting | Heart Health Research Center | 260 | 2026-07-13 | 2026-07-01 |
| Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease Finerenone (BAY 94-8862), Placebo - Albuminuria, Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 148 | 2026-07-01 | 2026-06-25 |
| Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence Finerenone - Atrial Fibrillation (AF) | Phase 2 | Recruiting | National Cheng-Kung University Hospital | 40 | 2026-06-09 | 2026-09-02 |
| A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction Finerenone (Kerendia, BAY94-8862) - Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | Phase 3 | Recruiting | Bayer | 117 | 2026-06-01 | 2026-10-15 |
| An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score Finerenone (Kerendia, BAY94-8862) - Chronic Kidney Disease, Type 2 Diabetes Mellitus | Recruiting | Bayer | 500 | 2026-05-26 | 2026-10-14 | |
| Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients Oral finerenone, Placebo - Heart Failure | Phase 4 | Not yet recruiting | China National Center for Cardiovascular Diseases | 104 | 2026-05-15 | 2026-05-13 |
| Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure Finerenone Oral Tablet, Finerenone Placebo - Acute Heart Failure | Phase 4 | Recruiting | Juntendo University | 550 | 2026-05-11 | 2026-08-10 |
| Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease Dulaglutide, SGLT2i, Finerenone - T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wannan Medical College | 468 | 2026-05-01 | 2026-04-22 |
| Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism Finerenone - Primary Aldosteronism, Endocrine Hypertension | Not applicable | Recruiting | Bangladesh Medical University | 104 | 2026-04-15 | 2026-07-07 |
Showing 20 of 95. Sign in to see all of them.
Renal Insufficiency, Chronic (39) · Diabetes Mellitus, Type 2 (28) · Heart Failure (20) · Diabetic Nephropathies (10) · Albuminuria (7) · Hyperaldosteronism (6) · Hypertension (5) · Kidney Diseases (4) · Proteinuria (4) · Diabetes Mellitus, Type 1 (3) · Glomerulonephritis, IGA (3) · Hyperkalemia (3) · Atrial Fibrillation (2) · Cardiovascular Diseases (2) · Diabetes Complications (2)
Bayer (39) · Colorado Prevention Center (3) · University Medical Center Groningen (3) · Alexandria University (2) · Assiut University (2) · Chongqing Medical University (2) · Peter Rossing (2) · Steno Diabetes Center Copenhagen (2) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · Bangladesh Medical University (1) · Baylor Research Institute (1) · Botkin Hospital (1) · Cathay General Hospital (1) · China National Center for Cardiovascular Diseases (1) · Chinese University of Hong Kong (1)
United States (29) · Germany (26) · Spain (23) · China (22) · Denmark (22) · Canada (18) · South Korea (18) · Taiwan (18) · Italy (17) · Czechia (14) · Israel (14) · Japan (14) · Portugal (14) · Bulgaria (13) · Netherlands (13)
Hiddo Lambers Heerspink (2) · Ping Li (2) · Ahmed A Ahmed, prof (1) · Ambarish Pandey, MD, MSCS (1) · Amy Mottl, MD, MPH (1) · Chris Wilcox, MD, PhD (1) · Dennis Kannenkeril, MD (1) · Hiddo J. Lambers Heerspink, Prof. Dr. (1) · Iain Bressendorff, MD PhD (1) · Jiguang Wang, MD. PhD (1) · Koichi Node, MD, PhD (1) · Mansour Saad Alqahtani, PhD Candidate (1)
PMID 33107592, PMID 40938666, PMID 33264825, PMID 33358451, PMID 38048573, PMID 41196655, PMID 31583611, PMID 33280027, PMID 34449181, PMID 34775784, PMID 36251465, PMID 36287567, PMID 36328655, PMID 36639130, PMID 36864892, PMID 36927680, PMID 37745646, PMID 38046911, PMID 38508632, PMID 38537621, PMID 39037799, PMID 39078403, PMID 39380152, PMID 40315020, PMID 40470996, PMID 40892478, PMID 41289823, PMID 41533467, PMID 41679125, PMID 41827014, PMID 42234437, PMID 22166847, PMID 22237748, PMID 22562554, PMID 22997344, PMID 23013602, PMID 23713082, PMID 25678098, PMID 25887073, PMID 26325557, PMID 27074824, PMID 27130705, PMID 27402170, PMID 27431783, PMID 30635226, PMID 30691124, PMID 30825073, PMID 31473020, PMID 31492486, PMID 31665733
2023 (6), 2015 (2), 2016 (2), 2025 (1)